Medindia
Medindia LOGIN REGISTER
Advertisement

US HealthConnect Inc. Continues Its Expansion in Medical Education Industry with the Acquisition of Medtelligence

Tuesday, November 27, 2018 Heart Disease News
Advertisement
Medtelligence becomes the newest member of the US HealthConnect group of companies that includes ReachMD, Omnia Education, Prova Education, and others
Advertisement

FORT WASHINGTON, Pa., Nov. 26, 2018 /PRNewswire-PRWeb/ -- US HealthConnect Inc. (USH) today announced the acquisition of Medtelligence LLC, one of the nation's leading providers of medical education focusing on cardiovascular disease. Medtelligence is the newest member of the USH group of companies, becoming the eighth wholly owned subsidiary. Each USH subsidiary is responsible for developing, delivering, and/or measuring the impact of clinical education on healthcare professionals.
Advertisement

Medtelligence President & CEO Kathleen Wickman, BSN, retains leadership of her team under the USH corporate infrastructure. "This is a valuable, strategic move for Medtelligence," said Wickman. "We have partnered with USH subsidiaries for years and have a long history of creating value in medical education. We look forward to continuing to provide new perspectives, educational creativity, and measurable outcomes in our industry."

The Medtelligence acquisition comes on the heels of significant growth across USH's medical education business units. "Our teams and our focus areas have expanded substantially," said Rob Braun, President of the USH group of CME companies: Omnia Education, Prova Education, ACCME-accredited TOPEC, and AGILE. "Medtelligence allows us to keenly focus on cardiovascular disease education and its impact on patient outcomes."

"Our teams of educational strategists could not be happier," said Ben Caref, PhD, Chief Medical Officer of Medtelligence. "We have spent many years designing and delivering important education across cardiovascular conditions, producing outcomes that show improvements in patient care and patient outcomes. We are excited to continue these efforts under the USH banner of companies."

Frank Russomano, President & CEO of USH, noted that 2019 marks the 20th anniversary of USH and that the continuing strategic growth plan has resulted in significant value for the companies. "We wholeheartedly welcome Kathy and her team to the USH family of companies," said Russomano. "We've gotten to know the entire Medtelligence team through a variety of projects over the years, and we know their commitment to excellence. They are an ideal fit as we continue to expand our footprint in the education industry."

About US HealthConnect Inc.

USH is a global organization whose subsidiaries are dedicated to improving the lives of patients and healthcare professionals through evidence-based education for clinicians. USH companies develop, produce, distribute, and measure the impact of education designed to improve the practice of medicine. USH subsidiaries include ReachMD, a multi-award winner by Medical Marketing & Media (MM&M) including Best Healthcare Professional Media Brand and Best Marketing Team; Omnia Education, a global leader in healthcare education for women's health providers; Prova Education, experts in adult professional learning in oncology, primary care, cardiology, auto-immune diseases, and many more clinical areas; AGILE, the Academy for Global Interprofessional Learning and Education, a Europe-based company offering education in multiple languages to healthcare professionals across the globe; Connect Healthcare Communications, a boutique strategic marketing firm focusing on drug and device marketing lifecycle management; and Winding River Productions, a full-service creative studio offering audio-visual and animation services, a full in-house production studio, and remote studios across the nation. Information is available at http://www.ushealthconnect.com. 

 

SOURCE US HealthConnect Inc.

Sponsored Post and Backlink Submission


Latest Press Release on Heart Disease News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close